Congratulations to Baebies for announcing it received clearance from the FDA for its SEEKER platform - the first Lysosomal Storage Disease newborn screening platform.
Following a panel review recommendation last August that unanimously supported approval, the FDA announced its clearance last week.
As Seeking Alpha put it: Who Loves Ya, Baebies?
This is a great milestone for Baebies, in which VentureSouth members invested in 2014 and last year, and another underline of the "Do Good" part of our motto - "Make Money. Have Fun. Do Good."